LIVALO pitavastatin 4 mg film-coated tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

pitavastatin calcium, Quantity: 4.18 mg (Equivalent: pitavastatin, Qty 4 mg)

Dostępny od:

Advantage Medical Products Consulting Pty Ltd

INN (International Nazwa):

pitavastatin calcium

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: aluminium magnesium silicate; lactose monohydrate; hypromellose; triethyl citrate; magnesium stearate; hyprolose; titanium dioxide; colloidal anhydrous silica

Droga podania:

Oral

Sztuk w opakowaniu:

100, 10, 30, 28

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Podsumowanie produktu:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '4' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Licence status A

Data autoryzacji:

2013-08-27